艾迪药业(688488)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688488 艾迪药业

已收盘 11-04 15:00:00

{"stockData":{"symbol":"688488","market":"SH","secType":"STK","nameCN":"艾迪药业","latestPrice":9.21,"timestamp":1730703600000,"preClose":8.77,"halted":0,"volume":9680476,"delay":0,"floatShares":421000000,"shares":421000000,"eps":-0.2485,"marketStatus":"已收盘","marketStatusCode":5,"change":0.44,"latestTime":"11-04 15:00:00","open":8.71,"high":9.34,"low":8.62,"amount":88332700,"amplitude":0.0821,"askPrice":9.21,"askSize":172,"bidPrice":9.2,"bidSize":1015,"shortable":0,"etf":0,"ttmEps":-0.2485,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1730770200000},"adr":0,"adjPreClose":8.77,"symbolType":"stock_kcb","openAndCloseTimeList":[[1730683800000,1730691000000],[1730696400000,1730703600000]],"highLimit":9.65,"lowLimit":7.89,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":420782808,"pbRate":3.62,"roa":"--","roe":"--","epsLYR":-0.18,"committee":0.532068,"marketValue":3875000000,"floatMarketCap":3875000000,"peRate":-37.062374,"changeRate":0.0502,"turnoverRate":0.023,"status":0,"afterMarket":{"amount":0,"volume":0,"close":9.21,"buyVolume":5000,"sellVolume":0,"time":1730705639464,"indexStatus":"已收盘 11-04 15:30:00","preClose":8.77}},"requestUrl":"/m/hq/s/688488","defaultTab":"news","newsList":[{"id":"2480034345","title":"艾迪药业大幅上涨 获主力净流入586万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480034345","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480034345?lang=zh_cn&edition=full","pubTime":"2024-11-04 10:28","pubTimestamp":1730687292,"startTime":"0","endTime":"0","summary":"11月04日，艾迪药业股价大幅上涨，截至10点28分，艾迪药业上涨5.25%，报9.23元/股，成交3885万元，换手率1.03%，振幅6.96%。资金动向截止发稿，艾迪药业获得主力净流入586万元，其中超大单流入639万元，大单流出52万元。融资融券方面，艾迪药业11月01日获得融资净买入100万元，当日该股融资余额为5047万元，当较前一日增加2.03%，实现3连增；该股融券余额为14万元，融券余量为1.56万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104102847ab9c6128&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104102847ab9c6128&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2480362263","title":"开源证券：给予艾迪药业买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2480362263","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480362263?lang=zh_cn&edition=full","pubTime":"2024-11-03 23:06","pubTimestamp":1730646377,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司余汝意,刘艺近期对艾迪药业进行研究并发布了研究报告《公司信息更新报告：抗艾新药持续放量，收购南大药业打造第二曲线》，本报告对艾迪药业给出买入评级，当前股价为8.77元。目前艾滋病产品临床研究证据不断完善，11次登上柳叶刀等权威学术期刊。最新盈利预测明细如下：该股最近90天内共有5家机构给出评级，买入评级4家，增持评级1家；过去90天内机构目标均价为18.61。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110300001908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688488","161027"],"gpt_icon":0},{"id":"2480809611","title":"艾迪药业（688488）2024年三季报简析：净利润减87.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480809611","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480809611?lang=zh_cn&edition=full","pubTime":"2024-11-01 06:28","pubTimestamp":1730413680,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期艾迪药业发布2024年三季报。根据财报显示，艾迪药业净利润减87.75%。截至本报告期末，公司营业总收入2.99亿元，同比下降0.89%，归母净利润-6094.16万元，同比下降87.75%。按单季度数据看，第三季度营业总收入1.18亿元，同比上升87.54%，第三季度归母净利润-1550.7万元，同比上升32.16%。持有艾迪药业最多的基金为财通优势行业轮动混合A，目前规模为6.07亿元，最新净值0.6416，较上一交易日上涨0.49%，近一年下跌3.46%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110100006036.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688488"],"gpt_icon":0},{"id":"2479745707","title":"艾迪药业(688488)9月30日股东户数1.01万户，较上期增加7.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479745707","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479745707?lang=zh_cn&edition=full","pubTime":"2024-10-31 17:12","pubTimestamp":1730365969,"startTime":"0","endTime":"0","summary":"证券之星消息，近日艾迪药业披露，截至2024年9月30日公司股东户数为1.01万户，较6月30日增加669.0户，增幅为7.06%。在生物制品行业个股中，艾迪药业股东户数低于行业平均水平，截至9月30日，生物制品行业平均股东户数为3.36万户。从股价来看，2024年6月30日至2024年9月30日，艾迪药业区间跌幅为8.32%，在此期间股东户数增加669.0户，增幅为7.06%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100033887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2479674528","title":"华安证券：给予艾迪药业买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2479674528","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479674528?lang=zh_cn&edition=full","pubTime":"2024-10-31 11:59","pubTimestamp":1730347191,"startTime":"0","endTime":"0","summary":"华安证券股份有限公司谭国超近期对艾迪药业进行研究并发布了研究报告《HIV新药及新适应症快速推进，南大药业并表》，本报告对艾迪药业给出买入评级，当前股价为8.9元。报告期内公司控股子公司南大药业正式并表。维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有5家机构给出评级，买入评级4家，增持评级1家；过去90天内机构目标均价为18.61。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100022387.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600909","688488"],"gpt_icon":0},{"id":"2479713696","title":"艾迪药业大幅上涨 获主力净流入149万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479713696","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479713696?lang=zh_cn&edition=full","pubTime":"2024-10-31 09:39","pubTimestamp":1730338765,"startTime":"0","endTime":"0","summary":"10月31日，艾迪药业股价大幅上涨，截至09点39分，艾迪药业上涨5.08%，报8.90元/股，成交1558万元，换手率0.42%。资金动向截止发稿，艾迪药业获得主力净流入149万元，其中超大单流入4万元，大单流入144万元。主营业务及业绩艾迪药业公司主营业务为探索、研发和销售创新性化学药物以及人源蛋白产品。最新财报显示，今年三季报，艾迪药业实现营业收入2.99亿元，同比减少0.89%，净利润为-6,094.16万元，同比减少87.75%，基本每股收益为-0.14元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031094016ab878b92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031094016ab878b92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2479313794","title":"艾迪药业（688488）10月30日主力资金净卖出8.23万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479313794","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479313794?lang=zh_cn&edition=full","pubTime":"2024-10-31 08:19","pubTimestamp":1730333953,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年10月30日收盘，艾迪药业报收于8.47元，下跌6.1%，换手率2.23%，成交量9.36万手，成交额8033.6万元。近5日资金流向一览见下表：艾迪药业融资融券信息显示，融资方面，当日融资买入423.45万元，融资偿还276.04万元，融资净买入147.41万元。艾迪药业主营业务：专注于医药领域,集药品研发、生产、销售于一体。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100011624.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2479118122","title":"艾迪药业大跌5.10% 2家券商给予增持建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2479118122","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479118122?lang=zh_cn&edition=full","pubTime":"2024-10-30 11:27","pubTimestamp":1730258844,"startTime":"0","endTime":"0","summary":"10月30日，艾迪药业股价大幅下跌，截至11点27分，艾迪药业下跌5.10%，报8.56元/股，成交3686万元，换手率1.00%，振幅4.55%。此外，数据统计显示，近半年内2家券商给予增持建议，6家券商给予买入建议。资金动向截止发稿，艾迪药业获得主力净流出310万元，其中超大单流出62万元，大单流出247万元。融资融券方面，艾迪药业10月28日获得融资净买入2万元，当日该股融资余额为4999万元，当较前一日增加0.06%；该股融券余额为15万元，融券余量为1.80万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030112941a1f74c95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030112941a1f74c95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2478127849","title":"艾迪药业10月28日遭主力抛售327万元 环比增加136.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478127849","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478127849?lang=zh_cn&edition=full","pubTime":"2024-10-28 15:20","pubTimestamp":1730100006,"startTime":"0","endTime":"0","summary":"10月28日, 艾迪药业股价涨3.79%，报收9.32元，成交金额6403万元，换手率1.66%，振幅5.35%，量比1.07。艾迪药业今日主力资金净流出327万元，连续4日净流出，上一交易日主力净流出138万元，今日环比增加136.96%。近一年数据显示，该股主力连续4日净流出后，次日下跌概率为72.73%，平均跌幅为2.69%。该股近5个交易日上涨7.00%，主力资金累计净流出484万元；近20日主力资金累计净流出548万元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028154629a1f1198e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028154629a1f1198e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0262","688488"],"gpt_icon":0},{"id":"2478671394","title":"艾迪药业10月25日遭主力抛售138万元 环比增加193.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478671394","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478671394?lang=zh_cn&edition=full","pubTime":"2024-10-25 15:19","pubTimestamp":1729840788,"startTime":"0","endTime":"0","summary":"10月25日, 艾迪药业股价涨0.67%，报收8.98元，成交金额5640万元，换手率1.50%，振幅3.48%，量比0.95。艾迪药业今日主力资金净流出138万元，连续3日净流出，上一交易日主力净流出47万元，今日环比增加193.62%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为43.75%，平均跌幅为4.27%。该股近5个交易日上涨3.58%，主力资金累计净流出573万元；近20日主力资金累计净流出227万元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025154037ab72c643&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025154037ab72c643&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2477333365","title":"艾迪药业：10月21日至10月22日高管王军减持股份合计27.22万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2477333365","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477333365?lang=zh_cn&edition=full","pubTime":"2024-10-22 20:01","pubTimestamp":1729598499,"startTime":"0","endTime":"0","summary":"证券之星消息，根据10月22日市场公开信息、上市公司公告及交易所披露数据整理，艾迪药业最新董监高及相关人员股份变动情况：2024年10月21日至2024年10月22日公司董事,高级管理人员王军共减持公司股份27.22万股，占公司总股本为0.0647%。变动期间公司股价上涨4.84%，10月22日当日收盘报9.09元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102200032935.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0262","688488"],"gpt_icon":0},{"id":"2477877003","title":"艾迪药业(688488.SH)董事兼副总裁王军完成减持69.21万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2477877003","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477877003?lang=zh_cn&edition=full","pubTime":"2024-10-22 19:28","pubTimestamp":1729596481,"startTime":"0","endTime":"0","summary":"智通财经APP讯，艾迪药业(688488.SH)公告，公司董事兼副总裁王军通过集中竞价减持的方式累计减持公司股份69.21万股，减持股份数量占公司总股本的0.16%，本次减持计划已实施完毕。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1197616.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0262","688488"],"gpt_icon":0},{"id":"2477381463","title":"艾迪药业新药销售不及同业，传统业务萎缩，并购大客户成扭亏曙光","url":"https://stock-news.laohu8.com/highlight/detail?id=2477381463","media":"时代周报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477381463?lang=zh_cn&edition=full","pubTime":"2024-10-22 18:30","pubTimestamp":1729593001,"startTime":"0","endTime":"0","summary":"艾迪药业聚焦抗艾滋病创新药及人源蛋白两大业务领域。此后，天普生化向艾迪药业的采购额大幅下滑。事实上，艾迪药业与南大药业之间构成了关联销售。截至10月18日收盘，艾迪药业的股价为8.67元/股，已破发37.88%，总市值为36.48亿元。艾迪药业此次将南大药业纳入控股子公司，有望通过并表增厚业绩，扭转当前的业绩颓势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102218303795bb1dbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102218303795bb1dbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2476442424","title":"艾迪药业大幅上涨 郑州金水产业投资基金合伙企业备案","url":"https://stock-news.laohu8.com/highlight/detail?id=2476442424","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476442424?lang=zh_cn&edition=full","pubTime":"2024-10-18 14:29","pubTimestamp":1729232972,"startTime":"0","endTime":"0","summary":"10月18日，艾迪药业股价大幅上涨，截至14点29分，艾迪药业上涨5.52%，报8.80元/股，成交4585万元，换手率1.28%。消息解读10月17日，郑州金水产业投资基金合伙企业在中基协备案。该基金规模50.01亿元，其中郑州金水投资集团认缴出资50亿元，深圳华信柏年股权投资基金管理有限公司认缴出资100万元。主营业务及业绩艾迪药业公司主营业务为探索、研发和销售创新性化学药物以及人源蛋白产品。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018144449a1e1a08d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018144449a1e1a08d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2476537901","title":"29家药企61名股东或高管减持股份！包括复星医药、艾迪药业等","url":"https://stock-news.laohu8.com/highlight/detail?id=2476537901","media":"中国制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476537901?lang=zh_cn&edition=full","pubTime":"2024-10-17 11:42","pubTimestamp":1729136525,"startTime":"0","endTime":"0","summary":"据业内统计，9月24日至10月16日午间收盘，A股 生物医药 板块有29家企业的61名股东或高管减持所持股份，包括 复星医药 、 艾迪药业 、 九典制药 、 新产业 等。其中， 贵州三力 、药康生物持股5%以上股东均在9月24日实现减持。本次权益变动后，该股东持有公司股份 2049.01万股，占公司总股本的比例为 4.999997%，不再是公司持股 5%以上的股东。例如，9月24日， 健之佳 5名高管扎堆减持；复星医药14名高管则在9月27日扎堆减持。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410171148139f4944b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410171148139f4944b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","688488","600196","BK0196","BK0239","BK0012","BK0060","BK0262","BK0096","BK0175","BK0188","BK0187","BK0183"],"gpt_icon":0},{"id":"2475460366","title":"艾迪药业：10月11日高管王军减持股份合计6.16万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2475460366","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475460366?lang=zh_cn&edition=full","pubTime":"2024-10-14 20:30","pubTimestamp":1728909002,"startTime":"0","endTime":"0","summary":"证券之星消息，根据10月14日市场公开信息、上市公司公告及交易所披露数据整理，艾迪药业最新董监高及相关人员股份变动情况：2024年10月11日公司董事,高级管理人员王军共减持公司股份6.16万股，占公司总股本为0.0146%。变动期间公司股价下跌7.54%，10月11日当日收盘报8.58元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101400028893.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2474909517","title":"艾迪药业：10月10日高管王军减持股份合计35.83万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2474909517","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474909517?lang=zh_cn&edition=full","pubTime":"2024-10-11 20:29","pubTimestamp":1728649754,"startTime":"0","endTime":"0","summary":"证券之星消息，根据10月11日市场公开信息、上市公司公告及交易所披露数据整理，艾迪药业最新董监高及相关人员股份变动情况：2024年10月10日公司董事,高级管理人员王军共减持公司股份35.83万股，占公司总股本为0.0851%。变动期间公司股价下跌0.64%，10月10日当日收盘报9.28元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101100036081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2474547260","title":"10月11日艾迪药业跌7.54%，财通优势行业轮动混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2474547260","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474547260?lang=zh_cn&edition=full","pubTime":"2024-10-11 16:21","pubTimestamp":1728634893,"startTime":"0","endTime":"0","summary":"证券之星消息，10月11日艾迪药业跌7.54%，收盘报8.58元，换手率1.96%，成交量8.23万手，成交额7211.78万元。根据2024基金半年报公募基金重仓股数据，重仓该股的公募基金共7家，其中持有数量最多的公募基金为财通优势行业轮动混合A。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101100023605.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0262","688488"],"gpt_icon":0},{"id":"2474608492","title":"艾迪药业大跌5.20% 2家券商给予增持建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2474608492","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474608492?lang=zh_cn&edition=full","pubTime":"2024-10-09 09:31","pubTimestamp":1728437503,"startTime":"0","endTime":"0","summary":"10月09日，艾迪药业股价大幅下跌，截至09点31分，艾迪药业下跌5.20%，报10.02元/股，成交331万元，换手率0.08%，振幅3.60%。此外，数据统计显示，近半年内2家券商给予增持建议，9家券商给予买入建议。融资融券方面，艾迪药业10月08日获得融资净买入1005万元，当日该股融资余额为4860万元，当较前一日增加26.07%，实现2连增；该股融券余额为9万元，融券余量为0.98万股，比上日减少12.46%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009135107ab68bd40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009135107ab68bd40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2473421534","title":"艾迪药业(688488.SH)：艾诺米替片新增适应症上市申请获得批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2473421534","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473421534?lang=zh_cn&edition=full","pubTime":"2024-10-08 20:25","pubTimestamp":1728390305,"startTime":"0","endTime":"0","summary":"智通财经APP讯，艾迪药业 发布公告，近日，公司收到国家药品监督管理局核准签发的《药品注册证书》，标志着公司抗艾滋病领域创新药复邦德新增适应症的药品注册上市许可申请获得批准。作为完整抗HIV方案，艾诺米替片口服单片复方制剂的组合方案系国际国内抗HIV临床实践指南推荐的标准治疗方案，进一步填补了该细分领域国产创新药空白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1191280.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688488","BK0262"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-07-20","address":"江苏省扬州市邗江区新甘泉西路69号","stockEarnings":[{"period":"1week","weight":-0.0118},{"period":"1month","weight":-0.0171},{"period":"3month","weight":-0.0065},{"period":"6month","weight":-0.4311},{"period":"1year","weight":-0.2731},{"period":"ytd","weight":-0.2638}],"companyName":"江苏艾迪药业股份有限公司","boardCode":"AI0041","perCapita":"41456股","boardName":"其他制造业","registeredCapital":"42078万元","compareEarnings":[{"period":"1week","weight":-0.0036},{"period":"1month","weight":-0.0079},{"period":"3month","weight":0.1545},{"period":"6month","weight":0.0581},{"period":"1year","weight":0.0922},{"period":"ytd","weight":0.1127}],"survey":"　　江苏艾迪药业股份有限公司主营业务以为HIV为主的抗病毒业务及人源蛋白业务。主要产品有乌司他丁、尤瑞克林、尿激酶等人源蛋白产品以及蜡样芽孢杆菌片、番泻叶颗粒、头孢拉定胶囊等制剂。公司荣获“2023年度扬州民营企业创新20强”、荣登“2022年度扬州市创新型企业50强”名单及“2022年度中国小分子药物企业创新力TOP30排行榜”。","serverTime":1730753195313,"listedPrice":13.99,"stockholders":"10150人(较上一季度增加7.06%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"艾迪药业(688488)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供艾迪药业(688488)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"艾迪药业,688488,艾迪药业股票,艾迪药业股票老虎,艾迪药业股票老虎国际,艾迪药业行情,艾迪药业股票行情,艾迪药业股价,艾迪药业股市,艾迪药业股票价格,艾迪药业股票交易,艾迪药业股票购买,艾迪药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"艾迪药业(688488)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供艾迪药业(688488)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}